Anixa Biosciences ANIX
NASDAQ ANIX
$2.95 +0.18 (+6.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Non Operating Investment Income (2012 - 2013)

Updated

Anixa Biosciences (ANIX) posted Non Operating Investment Income of $6,000 for FY2021 (year ended Oct 31, 2021), compared with -$148,084 in FY2020.

Analysis

Anixa Biosciences (ANIX) Non Operating Investment Income (2012 - 2013) Analysis & Trends

  • Business Quant data shows ANIX's Non Operating Investment Income at -$148,084 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Anixa Biosciences 102.02 Mn 100.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2013 290,194.00
Apr 30, 2012 -412,853.00
API Access

Anixa Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ANIX&period=max&api_key=YOUR_API_KEY